This issue of McDermott Will & Schulte’s Healthcare Regulatory Check-Up highlights regulatory activity for July 2025, including the results of the US Department of Justice’s (DOJ) 2025 National Health Care Fraud Takedown, DOJ and the US Department of Health and Human Services’ (HHS) new False Claims Act (FCA) Working Group, and three Office of Inspector General (OIG) advisory opinions. We discuss a pharmaceutical company’s challenge to the FCA qui tam provisions. This issue also reviews key proposals in the calendar year (CY) 2026 Physician Fee Schedule (PFS) proposed rule and the CY 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule, as well as finalized policies in the fiscal year (FY) 2026 Medicare Hospital In

See Full Page